RareShare Competitors

Meta's mission is to build the future of human connection and the technology that makes it possible. Our technologies help people connect, find communities, and grow businesses. When Facebook launched in 2004, it changed the way people connect. Apps like Messenger, Instagram and WhatsApp further empowered billions around the world. Now, Meta is moving beyond 2D screens toward immersive and intelligent experiences like virtual reality, wearables and AI to help build the next evolution in social technology. To help create a safe and respectful online space, we encourage constructive conversations on this page. Please note the following: • Start with an open mind. Whether you agree or disagree, engage with empathy. • Comments violating our Community Standards will be removed or hidden. Please treat everybody with respect. • Keep it constructive. Use your interactions here to learn about and grow your understanding of others. • Our moderators are here to uphold these guidelines for the benefit of everyone, every day. • If you are seeking support for issues related to your Facebook account, please reference our Help Center (https://www.facebook.com/help) or Help Community (https://www.facebook.com/help/community). For a full listing of our jobs, visit https://www.metacareers.com

The National Organization for Rare Disorders (NORD), a 501(c)(3) organization, is an independent patient advocacy organization dedicated to helping individuals with rare diseases and the organizations that serve them. NORD, along with its 350+ patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient support services. NORD serves all stakeholders in the rare disease community, including patients and their families, patient organizations, researchers, medical professionals, medical students, and companies developing orphan products. NORD also works closely with many government agencies, most notably the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). All NORD programs are focused on one ultimate goal: to improve the lives of individuals and families affected by rare diseases. NORD is the official U.S. sponsor of Rare Disease Day, an international observance day held on the last day of February each year. Its goals are to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. To learn more, visit rarediseases.org/rare-disease-day. To learn more, please visit the NORD website at www.rarediseases.org. You can also follow NORD on X at @RareDiseases.

Empowering the Next Generation Rare Disease Advocate. Global Genes and RARE-X officially merged into one organization December 2022 under the name Global Genes. Both organizations have been working toward the goal of empowering the next generation advocate both through their individual initiatives and their strategic partnership announced in 2021. RARE-X was born out of Global Genes after discussions with advocacy leaders, board members, partners, patients, and care partners, addressing a significant gap in access to tools, technology, and infrastructure. Hope. It’s in our genes.™